Cerebrum: Improving the Efficiency of Medical and Life Sciences Pathology Labs

Gregg Lahti, CEO and Founder
Medical and life sciences pathology labs still rely on manual ways to keep track of patient specimens, which leads to errors and delays in report generation. Be it an anatomic pathology (AP) lab or a clinical research organization (CRO), every entity relies on spreadsheets or physical handwritten relabeling of specimens. These methods are insufficient to manage their workflow as messy or illegible penmanship, and human error in retyping or printing results in misinterpretation. Moreover, AP labs and CROs need to follow stringent HIPAA guidelines to ensure the integrity, confidentiality, and availability of all specimen and process related data.. They also have to provide the whole data related to specimen tests—holding crucial information about specimen status, time, and the number of individuals involved in the process—to the FDA as a part of the clinical trial. Manual processes to keep track of this information often result in data loss, which might go unnoticed by the person performing the operation. To this end, AP labs and CROs need to have an automated solution to manage all of these processes while reducing the reimbursement prices for specimen testing.

With a comprehensive understanding of the scenario, Arizona-based firm, Cerebrum offers workflow automation software solutions to pathology practices that help them increase productivity, streamline workflow, avoid errors, and ensure compliance with stringent regulations. The company has designed a cloud-based solution, LABdivus, which tracks specimens accurately throughout the testing process—from accessioning to reporting. It helps pathologists prevent errors, improve productivity, and reduce turnaround time. By leveraging this software, pathology practices can also keep track of individuals’ activities involved in the testing process to ensure they work as per HIPAA guidelines. LABdivus also allows CROs to easily provide all the necessary data to the FDA as a part of drug trials. “From day one, it has been our mission to help clients improve efficiency and grow their business,” says Gregg Lahti, CEO and Founder, Cerebrum.

Apart from maintaining the FDA, CLIA and CAP inspection criteria, LABdivus has error checking and automated form completion capability that reduces the keystrokes required to perform an operation and generate a report. As a result, labs can increase their productivity four times compared to other solutions in the market. “Clients often provide us feedback on how our software drastically increased their efficiency in processing and signing out cases in the lab,” says Lahti.


Providing full control over data and organizing it properly, our software streamlines specimen processing in anatomic pathology labs from accession to pathologist diagnosis

“With our software, pathologists can quickly diagnose and sign out cases in seconds rather than minutes, enabling them to complete more work in less time. Our software gives a complete pathology report preview for the pathologist so they know exactly what they are signing out.”Working collaboratively with urology, dermatology, and gastroenterology labs, the company helps them manage their workflow and maximize laboratory efficiency in processing specimens, diagnosis, and billing. LABdivus further ensures specimen integrity by automating the specimen tracking process and eliminating human error. “Providing full control over data and organizing it properly, our software streamlines specimen tracking throughout the specimen testing process,” says Tom Miller, Director of Marketing at Cerebrum. “Our system connects the data workflow between the physician EMRs and billing, eliminating hand-entering patient data and billing information”.

Reaping the benefits of LABdivus, many clients developed their business over the years. For example, a small lab grew into a large laboratory by effectively diagnosing cases using LABdivus. Previously, the lab used different software solutions but weren’t satisfied with the outcomes. After utilizing LABdivus, they observed four times more efficiency in their processes and performance than the others. Cerebrum has also partnered with a large reference genomics lab to help build their genomics assay workflow. “We’ve enabled them to process over 100 million DNA tests a year and opened up several massive revenue streams for them,” says Lahti.

Leveraging its knowledge and expertise, Cerebrum is expanding its capabilities to build a genomics platform to dramatically reduce the experiment time to days instead of years. Cerebrum is continually learning and updating its understanding of the genomics field and adding new features to its product that will allow clients to quickly release new assays. It is also focusing on bringing in ERP solutions to eliminate the challenges that laboratories often face regarding resource management.

Company
Cerebrum

Headquarters
Chandler, AZ

Management
Gregg Lahti, CEO and Founder

Description
Arizona-based firm, Cerebrum offers workflow automation software solutions to pathology practices that help them increase productivity, streamline workflow, avoid errors, and ensure compliance with stringent regulations. The company has designed a cloud-based solution, LABdivus, which tracks specimens accurately throughout the testing process—from accessioning to reporting. It helps pathologists prevent errors, improve productivity, and reduce turnaround time. By leveraging this software, pathology practices can also keep track of individuals’ activities involved in the testing process to ensure they work as per HIPAA guidelines